(Q53107821)

11 May 2018

title

Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer. (English)

1 reference

11 May 2018

Daniela Pretti da Cunha Tirapelli

1 reference

1 reference

5

object named as

Daniela Pretti da Cunha Tirapelli

1 reference

11 May 2018

author name string

Ana Luiza Normanha Ribeiro de Almeida

1

1 reference

11 May 2018

Mário Vinícius Angelete Alvarez Bernardes

2

1 reference

11 May 2018

Marley Ribeiro Feitosa

3

1 reference

11 May 2018

Fernanda Maris Peria

4

1 reference

11 May 2018

José Joaquim Ribeiro da Rocha

6

1 reference

11 May 2018

Omar Feres

7

1 reference

11 May 2018

publication date

1 January 2016

1 reference

11 May 2018

Acta Cirurgica Brasileira

published in

1 reference

11 May 2018

volume

31 Suppl 1

1 reference

11 May 2018

page(s)

13-18

1 reference

11 May 2018

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Perineural invasion is an independent predictor of outcome in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Diagnostic and prognostic microRNAs in stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

The impact of microRNAs on colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

MicroRNAs as Novel Biomarkers in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Principles of microRNA-target recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Clinicopathological and Prognostic Value of MicroRNA-21 and MicroRNA-155 in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Circulating miR-34a levels are reduced in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Mir-34: a new weapon against cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0102-86502016001300004

10.1590/S0102-86502016001300004

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018